中华生物医学工程杂志
中華生物醫學工程雜誌
중화생물의학공정잡지
CHINESE JOURNAL OF BIOMEDICAL ENGINEERING
2014年
1期
29-33
,共5页
孙惠萍%王宝珠%马依彤%买苏木·买合木提%周欣荣%赵龙
孫惠萍%王寶珠%馬依彤%買囌木·買閤木提%週訢榮%趙龍
손혜평%왕보주%마의동%매소목·매합목제%주흔영%조룡
心肌梗死%脂肪干细胞%碱性成纤维生长因子
心肌梗死%脂肪榦細胞%堿性成纖維生長因子
심기경사%지방간세포%감성성섬유생장인자
Myocardial infarction%Adipose derived stem cell%Basic fibroblast growth factor
目的 探讨脂肪干细胞(ADSC)联合碱性成纤维生长因子(bFGF)提高心肌梗死大鼠心脏功能的可能机制.方法 SD大鼠50只,先行脂肪干细胞提取手术,分离、培养、鉴定脂肪干细胞,行干细胞成脂、成骨诱导分化,建立大鼠心肌梗死模型,选择缩短分数(FS)<40%的SD大鼠(36只),完全随机分4组:单纯注射PBS组(n=9)、单纯注射bFGF组(n=9)、PBS+ADSC组(n=9)以及ADSC+bFGF组(n=9),以bFGF胶为可注射性载体,ADSC为种子细胞,1周后进行大鼠心梗部位移植.移植4周后对心梗面积、左心室室壁厚度、心梗部位微血管密度、ADSC在心梗部位分化情况等指标进行检测,并利用心脏超声对心梗大鼠的心脏功能进行测定.应用免疫组织化学、免疫荧光等方法评价其改善心脏功能可能机制.结果 成功分离ADSC并且通过流式细胞术表明大多数分离的脂肪干细胞CD90抗体阳性、CD29抗体阳性、CD45抗体和CD34抗体阴性.脂肪干细胞能够经过诱导分化成成脂、成骨细胞.PBS+ADSC组以及ADSC+bFGF组在室壁厚度、梗死面积、梗死区域微血管形成能力与PBS组相比,差异均有统计学意义,且以ADSC+bFGF组最为显著(P<0.01).ADSC移植到大鼠心脏4周后,可以分化为cTnT阳性细胞、SMA阳性细胞以及vWAg阳性细胞.心功能检测结果表明PBS+ADSC组同ADSC+bFGF组一样,具有心梗修复能力.结论 移植ADSC的同时增加bFGF能促进梗死区的心肌再生以及血管化,并能显著改善心脏功能.
目的 探討脂肪榦細胞(ADSC)聯閤堿性成纖維生長因子(bFGF)提高心肌梗死大鼠心髒功能的可能機製.方法 SD大鼠50隻,先行脂肪榦細胞提取手術,分離、培養、鑒定脂肪榦細胞,行榦細胞成脂、成骨誘導分化,建立大鼠心肌梗死模型,選擇縮短分數(FS)<40%的SD大鼠(36隻),完全隨機分4組:單純註射PBS組(n=9)、單純註射bFGF組(n=9)、PBS+ADSC組(n=9)以及ADSC+bFGF組(n=9),以bFGF膠為可註射性載體,ADSC為種子細胞,1週後進行大鼠心梗部位移植.移植4週後對心梗麵積、左心室室壁厚度、心梗部位微血管密度、ADSC在心梗部位分化情況等指標進行檢測,併利用心髒超聲對心梗大鼠的心髒功能進行測定.應用免疫組織化學、免疫熒光等方法評價其改善心髒功能可能機製.結果 成功分離ADSC併且通過流式細胞術錶明大多數分離的脂肪榦細胞CD90抗體暘性、CD29抗體暘性、CD45抗體和CD34抗體陰性.脂肪榦細胞能夠經過誘導分化成成脂、成骨細胞.PBS+ADSC組以及ADSC+bFGF組在室壁厚度、梗死麵積、梗死區域微血管形成能力與PBS組相比,差異均有統計學意義,且以ADSC+bFGF組最為顯著(P<0.01).ADSC移植到大鼠心髒4週後,可以分化為cTnT暘性細胞、SMA暘性細胞以及vWAg暘性細胞.心功能檢測結果錶明PBS+ADSC組同ADSC+bFGF組一樣,具有心梗脩複能力.結論 移植ADSC的同時增加bFGF能促進梗死區的心肌再生以及血管化,併能顯著改善心髒功能.
목적 탐토지방간세포(ADSC)연합감성성섬유생장인자(bFGF)제고심기경사대서심장공능적가능궤제.방법 SD대서50지,선행지방간세포제취수술,분리、배양、감정지방간세포,행간세포성지、성골유도분화,건립대서심기경사모형,선택축단분수(FS)<40%적SD대서(36지),완전수궤분4조:단순주사PBS조(n=9)、단순주사bFGF조(n=9)、PBS+ADSC조(n=9)이급ADSC+bFGF조(n=9),이bFGF효위가주사성재체,ADSC위충자세포,1주후진행대서심경부위이식.이식4주후대심경면적、좌심실실벽후도、심경부위미혈관밀도、ADSC재심경부위분화정황등지표진행검측,병이용심장초성대심경대서적심장공능진행측정.응용면역조직화학、면역형광등방법평개기개선심장공능가능궤제.결과 성공분리ADSC병차통과류식세포술표명대다수분리적지방간세포CD90항체양성、CD29항체양성、CD45항체화CD34항체음성.지방간세포능구경과유도분화성성지、성골세포.PBS+ADSC조이급ADSC+bFGF조재실벽후도、경사면적、경사구역미혈관형성능력여PBS조상비,차이균유통계학의의,차이ADSC+bFGF조최위현저(P<0.01).ADSC이식도대서심장4주후,가이분화위cTnT양성세포、SMA양성세포이급vWAg양성세포.심공능검측결과표명PBS+ADSC조동ADSC+bFGF조일양,구유심경수복능력.결론 이식ADSC적동시증가bFGF능촉진경사구적심기재생이급혈관화,병능현저개선심장공능.
Objective To This project aimed to discover potential mechanism of treating myocardial infarction by transplantation of adipose-derived stem cells (ADSC) with basic fibroblast growth factor(bFGF).Methods ADSC were isolated from the fat tissue.These cells were cultured and induced to differentiate to the adipogenic cells,which were identified by rows stem cell adipogenic and osteogenic differentiation.Myocardial infarction (MI) model were conducted in 50 SD rats,and rats were randomized into 4 groups with the inclusion criterion of EF (ejection fraction) <40% by echocardiography 1 week after MI (PBS group,bFGF group,PBS+ADSC group,ADSC+bFGF group).bFGF was co-injected with ADSC into the left ventricular wall of MI rats.After 4 weeks,MI size,left ventricular wall thickness,MI parts micro-vessel density,ADSC differentiation at the MI site were detected and cardiac function measured by echocardiography.Immunohistochemistry and immunofluorescence were used to evaluate possible mechanism.Results ADSC were successfully isolated and most ADSC showed positive and CD90 and CD29 and negative,CD45 and CD34 by flow cytometry.ADSC could be differentiated into adipogenic,and osteogenic cells.PBS + ADSC group and ADSC + bFGF group showed statistically significant differences of angiogenesis,ventricular wall thickness MI size,MI regional capacity compared to PBS groups,especially ADSC+bFGF group (P<0.01).After 4 weeks of ADSC transplantation into rats,the cells could differentiate into positive cTnT,SMA positive cells and vWAg positive cells.Cardiac function test results showed that PBS+ADSC group had the same ability of repairment as ADSC+bFGF group.Conclusion Treatment of cotransplanting ADSC with bFGF can promote the regeneration of infarcted myocardium and blood vessels,and improve the cardiac function.